BGR GOVERNMENT AFFAIRS

Lobbying for BIOMARIN PHARMACEUTICAL INC. · Biotechnology company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $50,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

Provide strategic counsel and advocacy on issues relating to biopharmaceuticals for rare diseases driven by genetic causes generally, or BioMarin Pharmaceutical specifically.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.